Bruce Downey - Cardinal Health Independent Director
| CAH Stock | USD 102.91 0.30 0.29% |
Director
Mr. Bruce L. Downey serves as Independent Director of Cardinal Health Inc. Mr. Downey was Chairman and Chief Executive Officer of Barr Pharmaceuticals, Inc., a global generic pharmaceutical manufacturer, from 1994 to 2008. Mr. Downey has served on a parttime basis as a Partner of NewSpring Health Capital II, L.P., a VC firm, since 2009. Having spent 14 years as Chairman and Chief Executive Officer of Barr Pharmaceuticals, Mr. Downey brings to the Board substantial global healthcare experience in the areas of operations, management, regulatory compliance, finance, executive leadership, strategic planning, human resources and corporate governance. He also offers valuable experience in the pharmaceutical and growing international aspects of our businesses, having served as Chief Executive Officer of Barr Pharmaceuticals since 2009.
| Age | 72 |
| Tenure | 15 years |
| Address | 7000 Cardinal Place, Dublin, OH, United States, 43017 |
| Phone | 614 757 5000 |
| Web | https://www.cardinalhealth.com |
Cardinal Health Management Efficiency
The company has Return on Asset of 0.0279 % which means that on every $100 spent on assets, it made $0.0279 of profit. This is way below average. Cardinal Health's management efficiency ratios could be used to measure how well Cardinal Health manages its routine affairs as well as how well it operates its assets and liabilities. The Cardinal Health's current Return On Capital Employed is estimated to increase to 0.17, while Return On Tangible Assets are projected to decrease to 0.05. As of now, Cardinal Health's Total Current Assets are increasing as compared to previous years. The Cardinal Health's current Intangible Assets is estimated to increase to about 2.2 B, while Non Current Assets Total are projected to decrease to under 6.4 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Mark Mlotek | Henry Schein | 68 | |
| M Jacobs | McKesson | 68 | |
| James Rogers | Owens Minor | 70 | |
| Steven Paladino | Henry Schein | 67 | |
| Donald Kabat | Henry Schein | 80 | |
| Bradley Lerman | McKesson | 63 | |
| David Simmons | Owens Minor | 51 | |
| Alex Blanco | Patterson Companies | 57 | |
| James Wiltz | Patterson Companies | 71 | |
| Dominic Caruso | McKesson | 63 | |
| Robert Frenzel | Patterson Companies | 46 | |
| Lemuel Lewis | Owens Minor | 70 | |
| MChristine Jacobs | McKesson | 68 | |
| Barry Alperin | Henry Schein | 77 | |
| Chuck Graves | Owens Minor | N/A | |
| Anne Whittemore | Owens Minor | 72 | |
| John Buck | Patterson Companies | 66 | |
| Truitt Allcott | Owens Minor | N/A | |
| Trudi Allcott | Owens Minor | N/A | |
| Carol Raphael | Henry Schein | 75 | |
| Alton Irby | McKesson | 73 | |
Management Performance
| Return On Asset | 0.0279 |
Cardinal Health Leadership Team
Elected by the shareholders, the Cardinal Health's board of directors comprises two types of representatives: Cardinal Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardinal. The board's role is to monitor Cardinal Health's management team and ensure that shareholders' interests are well served. Cardinal Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardinal Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Meghan FitzGerald, Executive Vice President - Health Policy and Strategy | ||
| Patricia English, Senior President | ||
| John Losh, Independent Director | ||
| Kevin Moran, VP Relations | ||
| David Anderson, Independent Director | ||
| Pamela Kimmet, Chief Human Resource Officer | ||
| Lisa Capodici, Vice President Investor Relations | ||
| Michael Kaufmann, Chief Executive Officer, Director | ||
| John Weiland, Independent Director | ||
| Sheri Edison, Independent Director | ||
| Nancy Killefer, Independent Director | ||
| Patricia Hall, Independent Director | ||
| Stephen Mason, Chief Executive Officer - Medical Segment | ||
| Jon Giacomin, CEO of the Pharmaceutical Segment | ||
| Calvin Darden, Independent Director | ||
| Akhil Johri, Independent Director | ||
| Jorge Gomez, CFO | ||
| Michele Holcomb, Executive Vice President - Strategy and Corporate Development | ||
| Colleen Arnold, Independent Director | ||
| Carrie Cox, Independent Director | ||
| Dean Scarborough, Independent Director | ||
| Craig Cowman, Executive Services | ||
| Deborah Weitzman, Chief Distribution | ||
| Jason Hollar, Chief Financial Officer | ||
| Matt Sims, Vice Relations | ||
| Gregory Kenny, Independent Non-Executive Chairman of the Board | ||
| Donald Casey, CEO of Medical Segment | ||
| Victor Crawford, Chief Executive Officer - Pharmaceutical segment | ||
| George Barrett, Chairman, CEO and Chairman of Executive Committee | ||
| Jessica Mayer, Chief Legal and Compliance Officer | ||
| Clayton Jones, Independent Director | ||
| Craig Morford, Chief Legal and Compliance Officer | ||
| Bruce Downey, Independent Director | ||
| Mary Scherer, Senior Officer | ||
| Brian Rice, Executive Vice President, Chief Information Officer and Customer Support Services | ||
| David Evans, Interim Chief Financial Officer | ||
| Carole Watkins, Chief Human Resource Officer | ||
| Ola Snow, Chief Human Resource Officer | ||
| Patricia Morrison, Executive Vice President - Customer Support Services and Chief Information Officer | ||
| David King, Independent Director | ||
| Michael Losh, Director | ||
| Stephen Falk, Executive Vice President General Counsel, Corporate Secretary | ||
| Aaron Alt, Chief Officer | ||
| Sally Curley, Senior Vice President - Investor Relations | ||
| Michelle Greene, Exec Services |
Cardinal Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cardinal Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.0279 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 25.24 B | ||||
| Shares Outstanding | 243.23 M | ||||
| Shares Owned By Insiders | 0.58 % | ||||
| Shares Owned By Institutions | 90.37 % | ||||
| Number Of Shares Shorted | 8.71 M | ||||
| Price To Earning | 16.00 X | ||||
| Price To Book | 16.07 X |
Pair Trading with Cardinal Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardinal Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardinal Health will appreciate offsetting losses from the drop in the long position's value.Moving together with Cardinal Stock
| 0.65 | DRRX | Durect Earnings Call This Week | PairCorr |
Moving against Cardinal Stock
| 0.51 | SBFMW | Sunshine Biopharma | PairCorr |
The ability to find closely correlated positions to Cardinal Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardinal Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardinal Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardinal Health to buy it.
The correlation of Cardinal Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardinal Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardinal Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardinal Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardinal Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.Note that the Cardinal Health information on this page should be used as a complementary analysis to other Cardinal Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Cardinal Stock analysis
When running Cardinal Health's price analysis, check to measure Cardinal Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardinal Health is operating at the current time. Most of Cardinal Health's value examination focuses on studying past and present price action to predict the probability of Cardinal Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardinal Health's price. Additionally, you may evaluate how the addition of Cardinal Health to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Cardinal Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardinal Health. If investors know Cardinal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardinal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Dividend Share 1.998 | Earnings Share 2.52 | Revenue Per Share 859.435 | Quarterly Revenue Growth 0.116 |
The market value of Cardinal Health is measured differently than its book value, which is the value of Cardinal that is recorded on the company's balance sheet. Investors also form their own opinion of Cardinal Health's value that differs from its market value or its book value, called intrinsic value, which is Cardinal Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardinal Health's market value can be influenced by many factors that don't directly affect Cardinal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardinal Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardinal Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardinal Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.